Tag:Apollon

Apollon Formularies plc Acquires Intellectual Property From Aion Therapeutic  

APOLLON Formularies plc (AQSE: APOL) ("Apollon" or the "Company"), a UK based international pharmaceutical company trading on the Aquis Stock Exchange, and Aion Therapeutic Inc. (CSE: AION) ("Aion"), a...

Apollon Announces Joint Venture With Tri-Medi Canna In South Africa

Apollon Formularies plc (AQSE: APOL, "Apollon" or the "Company"), a UK based internationalpharmaceutical company trading on the Aquis Stock Exchange, is pleased to announce...

EU Cannabis Stocks Review: OCT’s Co-Founder Demands Removal Of All 6 Directors – More from Akanda, MGC Pharmaceuticals & Apollon

We start this week's EU Cannabis Stocks Review with some breaking news from Oxford Cannabinoid Technologies, after the company's co-founder calls for a general meeting in an attempt enact a dramatic management overhaul.

Latest news

European Cannabis Stocks Review: Celadon Shares Spike 150% On Licence Update, OCT Continues Recovery, & Creso Pharma Censured By ASX

Celadon Pharmaceuticals  Celadon Pharmaceuticals stock has skyrocketed by more than 150% this week following the announcement that its current Home...
- Advertisement -spot_imgspot_img

Benefits of F1 Cannabis Hybrids from Royal Queen Seeds

F1 hybrids have revolutionised the way we grow and use plants. Now, F1 cannabis seeds are bringing growers, smokers,...

Celadon Pharmaceuticals Announces Home Office Approval Of Licence For Commercial Sale Of GMP Cannabis

PRESS RELEASE FURTHER to the announcement dated 16 January 2023, Celadon Pharmaceuticals Plc (AIM: CEL), a UK-based pharmaceutical company focused on...

Must read